Evaluating Biosimilar Trastuzumab for Breast Cancer in Thailand
In a groundbreaking study published in BMC Health Services Research, researchers Lochid-amnuay and Kongsakon delve into the cost-utility and budget impact analysis of biosimilar trastuzumab for early-stage HER2-positive breast cancer in...
Read moreDetails





















